enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. The vaccine prevents dengue caused by all four dengue virus serotypes. Since 2022, Dengvaxia has been available for use in children and adolescents 9–16 years old who have laboratory-confirmed previous dengue virus infection and are living in an area where dengue is endemic.

  3. A dengue vaccine provides your child with safe, effective, and long-lasting protection against dengue illness, hospitalization, and severe disease. Children need to be tested to confirm a previous dengue infection before vaccination. Three doses of the vaccine are required for full protection.

  4. Vaccine Eligibility & Recommendations | Dengue | CDC

    www.cdc.gov/dengue/hcp/vaccine/eligibility.html

    Dengue is a disease caused by four distinct, but closely related dengue viruses, DENV-1–4. People can be infected with dengue multiple times. For people who have not had dengue before, the vaccine can increase the risk of severe infection. Learn how dengue vaccine eligibility relates to previous infection and when vaccination is recommended.

  5. Vaccine Schedule & Dosing | Dengue | CDC - Centers for Disease...

    www.cdc.gov/dengue/hcp/vaccine/schedule-dosing.html

    Information about Dengvaxia dengue vaccine schedule and dosing for healthcare providers.

  6. Vaccine Safety & Efficacy Data | Dengue | CDC - Centers for...

    www.cdc.gov/dengue/hcp/vaccine/safety-efficacy.html

    Dengvaxia is a dengue vaccine recommended for children 9 through 16 years old. Dengvaxia is safe when used in individuals with laboratory evidence of past dengue virus infection living in areas where dengue is common. It has an efficacy rate of about 80% against disease, hospitalization, and severe disease.

  7. Dengue Vaccine Recommendations - CDC

    www.cdc.gov/vaccines/vpd/dengue/hcp/recommendations.html

    For the full text of the recommendations, see Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021. Dengue vaccine is recommended for adolescents who are: 9–16 years old; Live in areas where dengue occurs frequently or continuously including: American Samoa; Puerto Rico; U.S. Virgin Islands

  8. Dengue Vaccine VIS | Vaccines & Immunizations | CDC

    www.cdc.gov/vaccines/hcp/current-vis/dengue.html

    Dengue vaccine can help protect against dengue in people who have had dengue in the past. Dengue is caused by one of four viruses spread through the bite of an infected mosquito. A person can get infected by any of the four dengue viruses.

  9. Vaccine Information Statement | Dengue | VIS | CDC

    www.cdc.gov/vaccines/hcp/vis/vis-statements/dengue.html

    Dengue vaccine can help protect against dengue in people who have had dengue in the past. Dengue is caused by one of four viruses spread through the bite of an infected mosquito. A person can get infected by any of the four dengue viruses.

  10. About how dengue spreads through mosquito bites and other routes. Dengue Learn about dengue viruses, how dengue spreads, how to prevent dengue, and the areas with risk of dengue.

  11. GRADE Analysis: Dengvaxia® Dengue Vaccine | ACIP | CDC

    www.cdc.gov/acip/grade/CYD-TDV-dengue-vaccine.html

    GRADE assessment for 3 doses of Dengue vaccine administered at 6-month intervals compared to no vaccine for protection against virologically confirmed dengue, severe dengue, and hospitalization among children ages 9-16 yrs with confirmed previous dengue infection, CYD-TDV Dengue Vaccine